There are 6 papers on MG-H1 in aging research: 1 trial and 2 observational studies in people, 3 in animals.
6 papers study it8 more mention it1 finding
- Human trial1
- Humans2
- Animals3
Interventions
1Gly-low
downin mice1
1 study
Gly-low
downin mice1
Gly-low decreases MG-H1 in mice.
“lowers the deleterious effects of glycation by reducing MGO and the MGO-derived AGE, MG-H1, in mice”
Animals
Cell reports
Latest
2 papers in 12 monthsDiabetes, Obesity & Metabolism
Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes
Cross-sectional study in peopleInsulin resistance
Free Radical Biology & Medicine
Methylglyoxal accumulation contributes to accelerated brain aging in spontaneously hypertensive rats
Experiments in ratsHypertension
International Journal of Hygiene and Environmental Health
The relationships between plasma advanced glycation end products level and cognitive function in middle-aged and elderly Chinese subjects
Cross-sectional study of 1,834 peoplePopulations
Clinical Chemistry and Laboratory Medicine
Homocitrulline and 3-year mortality in older hospitalised adults: an exploratory study
Cohort study of 250 peopleBiomarkers
Scientific Reports
Non-invasive evaluation of advanced glycation end products in hair as early markers of diabetes and aging
Study in peopleDiabetes mellitus
Clinical Nutrition
Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition
Cohort study of 93,830 peopleDementia